Home › Longkanker › Illinois › Joliet
Longkanker klinische studies in Joliet, IL
12 studies voor Longkanker zoeken deelnemers op locaties in en rond Joliet (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mijl verwijderd
- University of Chicago Medicine-Orland Park, Orland Park · 14 mijl verwijderd
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruterenFase 3
- Northwestern Medicine Orland Park, Orland Park · 14 mijl verwijderd
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Northwestern Medicine Orland Park, Orland Park · 14 mijl verwijderd
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RekruterenFase 2
- Hope and Healing Clinical Research, New Lenox · 6 mijl verwijderd
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Hope and Healing Cancer Services, New Lenox · 6 mijl verwijderd
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruterenFase 2
- Hope and Healing Clinical Research, New Lenox · 6 mijl verwijderd
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruterenFase 3
- Hope and Healing Cancer Services, New Lenox · 6 mijl verwijderd
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RekruterenFase 1/2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mijl verwijderd
- University of Chicago Medicine-Orland Park, Orland Park · 14 mijl verwijderd
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- University of Chicago, New Lenox · 6 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Northwestern Medicine Orland Park, Orland Park · 14 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Northwestern Medicine Orland Park, Orland Park · 14 mijl verwijderd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Northwestern Medicine Orland Park, Orland Park · 14 mijl verwijderd
Longkanker studies in andere steden
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Andere studies in Joliet
- Niet-kleincellige longkanker12 studies
- Metastatische kanker7 studies
- Blasenkanker7 studies
- Plaveiselcelcarcinoom van hoofd en hals6 studies
- Prostaatkanker5 studies
- Hypopharynxkanker5 studies
- Keelholtekanker5 studies
- Mondkanker5 studies
- Acute myeloïde leukemie5 studies
- Borstkanker4 studies
- Dikkedarmkanker4 studies
- Nierkanker (niercelcarcinoom)4 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.